What is NDC 0023-6153?

0023-6153 is the product NDC for Oxytrol (oxybutynin), Oxybutynin 3.9 mg/d patch, listed with the FDA by Allergan, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oxytrol?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oxytrol NDC 0023-6153 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0023-6153Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00023-6153Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0023-6153-08	00023615308	8 POUCH in 1 BOX (0023-6153-08) / 1 PATCH in 1 POUCH / 4 d in 1 PATCHMarketed from Feb 26, 2003

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxytrol
Generic name (nonproprietary): oxybutynin
Active ingredients: Oxybutynin — 3.9 mg/d
Dosage form: Patch
Route: Transdermal
Labeler: Allergan, Inc.NDC labeler code 0023
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021351
Marketing start: Feb 26, 2003
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 0023-6153_12aace89-ecb2-4706-a0bd-5bd24b8db2edSPL ID 12aace89-ecb2-4706-a0bd-5bd24b8db2edSPL set ID 20dee37f-1412-44ed-9e8b-f4379ce23eb0RxCUI 403799, 404448UNII K9P6MC7092
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400023615308 followed by a unit qualifier and the quantity

Package 00023-6153-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 29, 2024.

Indications (excerpt from the label)

OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder in men with symptoms of urge urinary incontinence, urgency, and frequency. OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder in men with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0023-6153

What is NDC 0023-6153?: 0023-6153 is the product NDC for Oxytrol (oxybutynin), Oxybutynin 3.9 mg/d patch, listed with the FDA by Allergan, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Oxytrol (Oxybutynin).
What is the active ingredient?: Oxybutynin.
Who is the labeler?: Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oxytrol?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Oxytrol (Oxybutynin) NDC 0023-6153